Home » Topics » Conferences

Conferences
RSS

Highly selective 5-HT1D agonists described by MS&D

Sep. 22, 1997

Taisho/Nihon Nohyaku evaluate thiazole derivatives as antipsychotics

Sep. 22, 1997

Eel calcitonin nasal spray evaluated in phase I

Sep. 22, 1997

Calcimimetic agent shown active in preclinical models of hyperparathyroidism

Sep. 22, 1997

Potent and selective 5-HT1D agonists under development at MS&D

Sep. 19, 1997

Taisho/Nihon Nohyaku identify potent and selective D4 receptor ligands

Sep. 19, 1997

New NO donor-containing NSAID derivatives from NitroMed

Sep. 19, 1997

PTH analogue restores bone mass in rabbits with glucocorticoid-induced osteopenia

Sep. 19, 1997

Lilly describes another SERM derived from raloxifene

Sep. 19, 1997

Mitsubishi comes up with a new conjugate of 17beta-estradiol and a bisphosphonate

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...